Social Motivation in Schizophrenia: The Impact of Oxytocin on Vigor in the Context of Social and Nonsocial Reinforcement

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Abnormal Psychology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1037/abn0000320PMID 29369669PMCID PMC7446385
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls

  2017cited by this paper
• Reward: From Basic Reinforcers to Anticipation of Social Cues.

  2017cited by this paper
• Effects of intranasal oxytocin on symptoms of schizophrenia: A multivariate Bayesian meta-analysis.

  2017cited by this paper
• Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward

  2017cited by this paper
• A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.

  2016cited by this paper
• Inefficient effort allocation and negative symptoms in individuals with schizophrenia.

  2016cited by this paper
• The Social Salience Hypothesis of Oxytocin.

  2016cited by this paper
• The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study

  2016cited by this paper
• Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials

  2016cited by this paper
• Effort-Based Decision Making: A Novel Approach for Assessing Motivation in Schizophrenia.

  2015cited by this paper
• Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1—Psychometric Characteristics of 5 Paradigms.

  2015cited by this paper
• Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2—External Validity and Correlates.

  2015cited by this paper
• Effort cost computation in schizophrenia: a commentary on the recent literature.

  2015cited by this paper
• Social approach and avoidance behaviour for negative emotions is modulated by endogenous oxytocin and paranoia in schizophrenia.

  2014cited by this paper
• Using self-determination theory to understand motivation deficits in schizophrenia: the 'why' of motivated behavior.

  2014cited by this paper
• Effort, anhedonia, and function in schizophrenia: reduced effort allocation predicts amotivation and functional impairment.

  2014cited by this paper
• Oxytocin administration enhances controlled social cognition in patients with schizophrenia.

  2014cited by this paper
• Domain-specific hedonic deficits towards social affective but not monetary incentives in social anhedonia

  2014cited by this paper
• Do people with schizophrenia have difficulty anticipating pleasure, engaging in effortful behavior, or both?

  2014cited by this paper
• I don’t care about others’ approval: Dysphoric individuals show reduced effort mobilization for obtaining a social reward

  2014cited by this paper
• Oxytocin, motivation and the role of dopamine.

  2014cited by this paper
• Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making.

  2013cited by this paper
• Ecological Momentary Assessment of social functioning in schizophrenia: impact of performance appraisals and affect on social interactions.

  2013cited by this paper
• Oxytocin influences processing of socially relevant cues in the ventral tegmental area of the human brain.

  2013cited by this paper
• Intranasal administration of oxytocin: Behavioral and clinical effects, a review

  2013cited by this paper
• The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.

  2013cited by this paper
• Negative symptoms of schizophrenia are associated with abnormal effort-cost computations.

  2013cited by this paper
• A Direct Examination of the Effect of Intranasal Administration of Oxytocin on Approach-Avoidance Motor Responses to Emotional Stimuli

  2013cited by this paper
• An interaction between oxytocin and a genetic variation of the oxytocin receptor modulates amygdala activity toward direct gaze: evidence from a pharmacological imaging genetics study

  2013cited by this paper
• Oxytocin enhances brain reward system responses in men viewing the face of their female partner

  2013cited by this paper
• Oxytocin and social salience: a call for gene-environment interaction research

  2013cited by this paper
• Negative correlation between cerebrospinal fluid oxytocin levels and negative symptoms of male patients with schizophrenia.

  2012cited by this paper
• The mysterious motivational functions of mesolimbic dopamine.

  2012cited by this paper
• Social anhedonia and affiliation: examining behavior and subjective reactions within a social interaction.

  2012cited by this paper
• The social motivation theory of autism.

  2012cited by this paper
• From perception to functional outcome in schizophrenia: modeling the role of ability and motivation.

  2012cited by this paper
• Social effects of oxytocin in humans: context and person matter.

  2011cited by this paper
• The Role of Oxytocin in Human Affect

  2011cited by this paper
• The role of motivation for treatment success.

  2011cited by this paper
• Why Don't You Try Harder? An Investigation of Effort Production in Major Depression

  2011cited by this paper
• Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia.

  2011cited by this paper
• Selective influences of oxytocin on the evaluative processing of social stimuli

  2011cited by this paper
• Vigor in the Face of Fluctuating Rates of Reward: An Experimental Examination

  2011cited by this paper
• The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis.

  2011cited by this paper
• Reconsidering anhedonia in depression: lessons from translational neuroscience.

  2011cited by this paper
• Evaluation of Enzyme Immunoassay and Radioimmunoassay Methods for the Measurement of Plasma Oxytocin

  2011cited by this paper
• A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research.

  2011cited by this paper
• Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.

  2010cited by this paper
• Oxytocin Attenuates Amygdala Reactivity to Fear in Generalized Social Anxiety Disorder

  2010cited by this paper
• Emotional experience in patients with schizophrenia revisited: meta-analysis of laboratory studies.

  2010cited by this paper
• Effects of oxytocin on recollections of maternal care and closeness

  2010cited by this paper
• Negative symptoms in schizophrenia: avolition and Occam's razor.

  2010cited by this paper
• Decision making and the avoidance of cognitive demand.

  2010cited by this paper
• Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

  2010cited by this paper
• Priorities and preferences for the outcomes of treatment of psychosis: A service user perspective

  2010cited by this paper
• Bridging the gap between extrinsic and intrinsic motivation in the cognitive remediation of schizophrenia.

  2010cited by this paper
• Motivation and its relationship to neurocognition, social cognition, and functional outcome in schizophrenia.

  2009cited by this paper
• Anticipation of monetary and social reward differently activates mesolimbic brain structures in men and women.

  2009cited by this paper
• The social world of the socially anhedonic: Exploring the daily ecology of asociality

  2009cited by this paper
• Dopaminergic-neuropeptide interactions in the social brain.

  2009cited by this paper
• Worth the ‘EEfRT’? The Effort Expenditure for Rewards Task as an Objective Measure of Motivation and Anhedonia

  2009cited by this paper
• Demand Characteristics and the Concept of Quasi-Controls1

  2009cited by this paper
• Sharing secrets: Oxytocin and trust in schizophrenia

  2009cited by this paper
• The Good-Subject Effect: Investigating Participant Demand Characteristics

  2008cited by this paper
• Empathic abilities in people with schizophrenia.

  2008cited by this paper
• When the Need to Belong Goes Wrong

  2007cited by this paper
• Patients with schizophrenia demonstrate dissociation between affective experience and motivated behavior.

  2007cited by this paper
• Tonic dopamine: opportunity costs and the control of response vigor

  2007cited by this paper
• Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure.

  2007cited by this paper
• Social Cognition in Schizophrenia: An Overview

  2007cited by this paper
• Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits

  2007cited by this paper
• Dopamine, learning, and reward-seeking behavior.

  2007cited by this paper
• The functional significance of social cognition in schizophrenia: a review.

  2006cited by this paper
• What does the PANSS mean?

  2005cited by this paper
• Sex Differences in Hormonal Modulation of Anxiety Measured with Light-Enhanced Startle: Possible Role for Arginine Vasopressin in the Male

  2005cited by this paper
• The Empathy Quotient: An Investigation of Adults with Asperger Syndrome or High Functioning Autism, and Normal Sex Differences

  2004cited by this paper
• Sex and species differences in plasma oxytocin using an enzyme immunoassay

  2004cited by this paper
• Measuring empathy: reliability and validity of the Empathy Quotient

  2004cited by this paper
• Wechsler Adult Intelligence Scale-III

  2001cited by this paper
• Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study.

  2000cited by this paper
• The Intensity of Emotion

  1999cited by this paper
• Anhedonia, positive and negative affect, and social functioning in schizophrenia.

  1998cited by this paper
• Relationship between cognitive and social dysfunction in schizophrenia.

  1998cited by this paper
• Self-report measurement of adult attachment: An integrative overview.

  1998cited by this paper
• Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders.

  1998cited by this paper
• The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.

  1997cited by this paper
• Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication.

  1994cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Scales for physical and social anhedonia.

  1976cited by this paper
• Effects of deceiving and debriefing psychological subjects on performance in later experiments.

  1970cited by this paper
• Neuroscience and Biobehavioral Reviews Problems with measuring peripheral oxytocin: Can the data on oxytocin and human behavior be trusted?

  year unknowncited by this paper

• Asociality in schizophrenia: A review of historical foundations, measures, mechanisms, and treatments.

  2026cites this paper
• Predicting Social Motivation and Interactions in Schizophrenia: An Ecological Momentary Assessment Study.

  2026cites this paper
• Social effort discounting reveals domain-general and social-specific motivation components.

  2024cites this paper
• Social cognition and social motivation in schizophrenia and bipolar disorder: are impairments linked to the disorder or to being socially isolated?

  2024cites this paper
• Social Motivation in Schizophrenia: What's Effort Got to Do With It?

  2023cites this paper
• Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia.

  2023cites this paper
• Validation of the Social Effort and Conscientious Scale (SEACS) in Schizophrenia

  2023cites this paper
• Oxytocin: An Old Hormone, A Novel Psychotropic Drug And Possible Use In Treating Psychiatric Disorders.

  2022cites this paper
• Anhedonia in Schizophrenia.

  2022cites this paper
• The (un)learning of social functions and its significance for mental health.

  2022cites this paper
• Motivation Disorders in Patients with Schizophrenia

  2022cites this paper
• Aberrant reward processing to positive versus negative outcomes across psychotic disorders.

  2022cites this paper
• Altered neural mechanism of social reward anticipation in individuals with schizophrenia and social anhedonia

  2022cites this paper
• Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment

  2021cites this paper
• Exogenous effects of oxytocin in five psychiatric disorders: a systematic review, meta-analysis and a personalized approach through the lens of the social salience hypothesis.

  2020cites this paper
• Imaging the "social brain" in schizophrenia: A systematic review of neuroimaging studies of social reward and punishment.

  2020cites this paper
• Effort shapes social cognition and behaviour: A neuro-cognitive framework.

  2020cites this paper
• Parsing social motivation: development and validation of a self-report measure of social effort

  2020cites this paper
• Learning and Motivation for Rewards in Schizophrenia: Implications for Behavioral Rehabilitation

  2020cites this paper
• Complementary Neural Circuits for Divergent Effects of Oxytocin: Social Approach Versus Social Anxiety.

  2019cites this paper
• At Issue: Are Negative Symptoms Merely the "Real World" Consequences of Deficits in Social Cognition?

  2019cites this paper
• Reward processing and social functioning in psychosis

  2019cites this paper
• Social motivation in schizophrenia: How research on basic reward processes informs and limits our understanding.

  2018cites this paper